News

FierceBiotech28d
To Gilead’s new CMO, pipeline diversification is key
Dietmar Berger, M.D., Ph.D., joined Gilead Sciences as chief medical officer at the start of this year after the company’s oncology department suffered some prominent setbacks. The run of bad ...
NBC 10 Philadelphia20d
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer - NBC10 Philadelphia
Berger said there are early signs that the combination may also help patients live longer, but the data is still new. Gilead is also studying Trodelvy as a first-line treatment in another type of ...
Oncology Nurse Advisor10d
Sacituzumab Govitecan Meets Endpoint in First-Line mTNBC Trial
The ASCENT-03 trial is a phase 3 study assessing the efficacy and safety of sacituzumab govitecan compared with physician’s choice of treatment in patients with previously untreated, locally advanced, ...
Reuters2mon
Gilead says Trodelvy-Keytruda combo effective for aggressive breast cancer type - Reuters
Dietmar Berger, Gilead's chief medical officer, said that with current treatment, patients can expect five to seven months of progression-free survival - the time until the disease begins to worsen.
Hosted on MSN2mon
Dietmar Mössmer: 'Donna Leon' star dies at 69 - MSN
Tyrolean actor Dietmar Mössmer passed away on Friday at the age of 69. He became well-known especially for his role as Sergente Alvise in the 'Donna Leon' TV adaptations. He was also connected to ...
NBC 6 South Florida20d
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer - NBC 6 South Florida
Berger said there are early signs that the combination may also help patients live longer, but the data is still new. Gilead is also studying Trodelvy as a first-line treatment in another type of ...
NBC Bay Area20d
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer - NBC Bay Area
Berger said there are early signs that the combination may also help patients live longer, but the data is still new. Gilead is also studying Trodelvy as a first-line treatment in another type of ...
NBC Washington20d
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer - NBC4 Washington
Berger said there are early signs that the combination may also help patients live longer, but the data is still new. Gilead is also studying Trodelvy as a first-line treatment in another type of ...
NBC New York20d
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer - NBC New York
Berger said there are early signs that the combination may also help patients live longer, but the data is still new. Gilead is also studying Trodelvy as a first-line treatment in another type of ...
NBC Los Angeles20d
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer - NBC Los Angeles
Berger said there are early signs that the combination may also help patients live longer, but the data is still new. Gilead is also studying Trodelvy as a first-line treatment in another type of ...
NBC DFW20d
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer - NBC 5 Dallas-Fort Worth
Berger said there are early signs that the combination may also help patients live longer, but the data is still new. Gilead is also studying Trodelvy as a first-line treatment in another type of ...
NBC Chicago20d
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer - NBC Chicago
Berger said there are early signs that the combination may also help patients live longer, but the data is still new. Gilead is also studying Trodelvy as a first-line treatment in another type of ...